1120-1121 / 2953
Final Remarks
• SBRT is currently widely accepted as the best alternative
to surgery for inoperable early stage lung cancer
• SBRT might be offered also to operable patients
• IGRT-motion management are essential for prescribing
high BED: IMRT is an option
• Mature data with long-term follow up are needed to
better understand the pattern of relapse across time
• Predictive and prognostic factors are needed to possibly
offer to higher risk patients adjuvant therapies